Companies /Healthcare

Aptargroup Inc

NYSE: ATR Medical Instruments & Supplies

24/7 Wall St. View

ATR at a Glance

Valuation
Market cap
$7.6B
P/E ratio
21.8
Dividend yield
1.57%
Profitability
Revenue (TTM)
$3.9B
Profit margin
9.2%
EPS (TTM)
$5.52
Price
52-week range
$102 – $146
24/7 target
$167.61
Street target
$167.57
Earnings
Next report
Oct 29, 2026

Headquartered in Crystal Lake, IL Fiscal year ends December NYSE: ATR aptar.com

About AptarGroup

AptarGroup, Inc. is a global provider of drug delivery, dosing and protection technologies, and consumer product dispensing solutions. The company operates through three segments: Pharma, which serves the pharmaceutical and healthcare industries with dispensing systems for prescription drugs, consumer healthcare products, and injectable applications including biologics and GLP-1 therapies; Beauty, which provides dispensing and packaging solutions for prestige fragrance, color cosmetics, hair care, and skin care markets; and Closures, which produces dispensing closures for beverage, food, and other consumer product applications. Aptar partners with top healthcare and consumer brands worldwide, leveraging proprietary design, engineering, and science capabilities to develop innovative solutions. The company employs approximately 14,000 people across 20 countries and trades on the NYSE under the ticker ATR. Updated

ATR Coverage

Frequently Asked Questions

What does AptarGroup do?

AptarGroup, Inc. is a global provider of drug delivery, dosing and protection technologies, and consumer product dispensing solutions.

What is the ATR stock price target?

24/7 Wall St.'s 12-month price target for ATR is $167.61, rated Buy. The Wall Street consensus target is $167.57. ATR price prediction →